CM Life Sciences II Inc.
CM Life Sciences II Inc. (CMII) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmii · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CM Life Sciences II Inc.You CMII | $2.0B | N/A | — | — |
 Apex Treasury Corporation Class A APXT | $1.9B | 58.46x | +36.6% | $0.17 |
 Trump Media & Technology Group Corp. DJT | $2.3B | N/A | — | -$2.79 |
 dMY Technology Group, Inc. III DMYI | $2.1B | N/A | — | -$1.82 |
 Fortress Value Acquisition Corp. II FAII | $2.1B | N/A | — | -$0.04 |
 Grindr Inc. GRND | $2.0B | 27.11x | -36.6% | $0.50 |
 Mudrick Capital Acquisition Corporation II MUDS | $2.0B | N/A | — | -$0.05 |
Industry Average 2 peers with valid PE | — | 42.78x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CM Life Sciences II Inc. (CMII) measures how much investors pay for each dollar of the company's trailing earnings. CMII's current PE ratio of N/A is calculated by dividing its stock price of $10.63 by its TTM earnings per share of —.
Frequently asked questions
CMII pe ratio · 6 questionsCMII's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.63 and TTM EPS of —. Data sourced from Financial Modeling Prep via CMII's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CM Life Sciences II Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09